within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AX02_AnetholeTrithione;

model AnetholeTrithione
  extends Pharmacolibrary.Drugs.ATC.A.A16AX02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A16AX02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Anethole trithione is a synthetic compound previously used as a choleretic agent to stimulate bile secretion. It has also been investigated for the treatment of dry mouth (xerostomia) in patients with various medical conditions, including Sj√∂gren's syndrome, and as an adjunct therapy in some cancer indications. Its clinical use today is very limited or largely discontinued in most countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a healthy adult oral administration; no direct clinical PK study available for anethole trithione.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AnetholeTrithione;
